Conferences
Upcoming MDPI Conferences (0)
No conferences found for the selection.Upcoming Partner Conferences (3)
Montpellier, France
The 12th Antibody Industrial Symposium AIS2024, jointly organized by the scientific society LabEx MAbImprove and MabDesign, the French association of the Biotherapy Industrial sector, will be held on June 20–21 2024, in Montpellier, France. The AIS2024 is the ideal conference for scientists, industrials, clinicians, and policy makers to discuss therapeutic antibodies and more! This year’s 2-day-programme is organized into several segments covering the hot topics in research on antibodies, recombinant proteins, CART cells and other biopharmaceuticals and development. Moreover, the program will allow opportunities for one-to-one meetings and companies to virtually showcase their new products and technologies with dedicated time for business partnering.
Call for Abstracts: Submit your Abstract to give a Pitch presentation or present your Poster at the AIS2024. The abstract submission deadline is April 12th, 2024! Check the guidelines at https://aiscongress.com/abstracts.php.
Key words: mAbs; bi- and multi-specifics; immunotherapy; developability; Ab-like molecules; immunocytokines; adoptive cell therapy; CAR-T cells; drug discovery; ADCs; analytics; patient stratification; PK/PD; AI and machine learning; bioprocessing
San Diego, CA, USA
Antibody Engineering & Therapeutics is bringing the buzz once again to our flagship event location in San Diego at Marriott Marquis on December 15–18, 2024.
By presenting the scientific agenda that has been carefully curated with The Antibody Society, there is no better place to ensure you receive the need-to-know updates. Immerse yourself in leading discussions from pioneers in the field, latest research and insights that are shaping the future of the industry, and access unparalleled networking opportunities with potential partners, peers, and leaders.
The 2024 event will cover the following 16 critical topic streams:
- Antibody Discovery and Selection;
- Emerging Library and Display Technologies;
- Quantitative Systems Pharmacology for Antibody Drugs;
- Antibody Therapies for Neurodegenerative Diseases;
- Machine Learning and AI in Antibody Discovery;
- Antibody-Based Degraders for Therapeutic Development;
- Antibody–Drug Conjugates: Clinical Lessons Learned;
- Antibody Drugs in the Clinic and Clinical Translation;
- Novel Bispecific and Multi-Specific Antibodies;
- Combination Antibody Therapies;
- Radiolabeled Antibodies;
- Antibody Repertoires and New Approaches for Antigen Discovery;
- Fc Engineering to Improve Therapeutic Effects;
- Antibody and Protein Engineering in Cell Therapy Applications;
- MRNA Delivery of Antibodies;
- Weird/Unusual Antibodies for Therapeutic Applications.
Furthermore, you can obtain a 10% discount on your pass when you enter the code MDPI10 at checkout, and the earlier you register, the more you save.
https://informaconnect.com/antibody-engineering-therapeutics/
Stockholm, Sweden
The 17th Annual World Cancer Congress (WCC-2025) will be held on June 18–20, 2025, in Stockholm, Sweden. We would like to extend a warm welcome to all distinguished guests from all over the world.
The Annual World Cancer Congress (WCC), initiated in 2008, has been successfully organized in Dalian (China), Shanghai (China), Beijing (China), Nanjing (China), Xi’an (China), Philadelphia (USA), Tokyo (Japan), Lisbon (Portugal), Barcelona (Spain), Osaka (Japan), and Budapest (Hungary) and has attracted more than 5000 participants from over 50 countries and regions in the previous 16 years. The 17th annual meeting will offer the chance to meet and hear about the latest developments from the most prestigious researchers in the field. The scientific program will cover a wide variety of subjects in the field of basic cancer research, screening and diagnosis, cancer therapies, new drug trials, and epidemiology and prevention, providing a platform to all experts to discuss the latest research and achievements.
